ANI Pharmaceuticals, Inc.

ANIP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$19$19-$48-$43
Dep. & Amort.$68$60$60$47
Deferred Tax-$22-$12-$15-$17
Stock-Based Comp.$29$21$15$10
Change in WC-$11$25-$51-$0
Other Non-Cash$19$7$9$5
Operating Cash Flow$64$119-$31$3
Investing Activities
PP&E Inv.-$16-$9-$9-$3
Net Acquisitions-$401$0-$0-$84
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$13-$10-$7-$18
Investing Cash Flow-$405-$19-$16-$105
Financing Activities
Debt Repay.$345-$3-$3$99
Stock Issued$0$81$0$70
Stock Repurch.-$11-$5-$2-$1
Dividends Paid-$2-$2-$2-$0
Other Fin. Act.-$68-$4$1$27
Financing Cash Flow$265$67-$5$195
Forex Effect-$0$0$0$0
Net Chg. in Cash-$76$168-$52$92
Supplemental Information
Beg. Cash$221$53$105$13
End Cash$145$221$53$105
Free Cash Flow$47$100-$48-$20
ANI Pharmaceuticals, Inc. (ANIP) Financial Statements & Key Stats | AlphaPilot